ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 44 filers reported holding ELIEM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,409 | -6.1% | 11,182 | 0.0% | 0.00% | – |
| Q2 2023 | $31,310 | -4.0% | 11,182 | -0.6% | 0.00% | – |
| Q1 2023 | $32,616 | -22.7% | 11,247 | -2.1% | 0.00% | – |
| Q4 2022 | $42,183 | +14.0% | 11,494 | 0.0% | 0.00% | – |
| Q3 2022 | $37,000 | +5.7% | 11,494 | 0.0% | 0.00% | – |
| Q2 2022 | $35,000 | -92.5% | 11,494 | -79.3% | 0.00% | – |
| Q1 2022 | $466,000 | -27.3% | 55,581 | -9.3% | 0.00% | – |
| Q4 2021 | $641,000 | -42.6% | 61,295 | -1.2% | 0.00% | – |
| Q3 2021 | $1,116,000 | – | 62,036 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,150,849 | $236,452,000 | 3.28% |
| Monashee Investment Management LLC | 305,233 | $5,488,000 | 1.01% |
| SAMLYN CAPITAL, LLC | 1,681,025 | $30,225,000 | 0.40% |
| Woodline Partners LP | 387,224 | $6,962,000 | 0.11% |
| TUDOR INVESTMENT CORP ET AL | 287,294 | $5,166,000 | 0.08% |
| CAAS CAPITAL MANAGEMENT LP | 75,000 | $1,349,000 | 0.03% |
| Hudson Bay Capital Management LP | 100,000 | $1,798,000 | 0.02% |
| GOLDMAN SACHS GROUP INC | 165,952 | $2,984,000 | 0.00% |
| HRT FINANCIAL LP | 11,797 | $212,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 71,983 | $1,294,000 | 0.00% |